Deanne Cuda

Enable Biosciences (United States)

Papers

1

Total Citations

32

H-Index

1

About

Deanne Cuda is a leading researcher in clinical immunology and infectious disease diagnostics, with a particular focus on high-throughput serological testing. Her most cited work, published in 2020, addresses the urgent global need for reliable SARS-CoV-2 antibody detection during the COVID-19 pandemic. Cuda developed a sensitive and specific assay using a fully automated liquid-handling robotic system, enabling rapid, large-scale serosurveillance. This innovation has been cited 32 times, reflecting its critical role in community screening, infection prevalence assessment, and patient identification during a time when over 14.7 million infections were confirmed worldwide. Her contributions exemplify the integration of automation and precision medicine, advancing the capacity for real-time pandemic response. Cuda’s work not only showcases technical ingenuity but also underscores her commitment to public health, making her a pivotal figure in the evolution of scalable diagnostic platforms for emerging infectious threats.

Research Focus

Key Achievements

1
H-Index
1
Papers
32
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Sensitive and Specific Detection of SARS-CoV-2 Antibodies Using a High-Throughput, Fully Automated Liquid-Handling Robotic System
32 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Enable Biosciences (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 4 days ago